• About Us
    • Overview
    • Our Leadership
    • Milestones
    • Group Companies
      • Zuventus
      • Gennova
      • Tillomed
      • Marcan
      • Mantra
      • Emcutix
  • Science & Innovation
    • Overview
    • Formulations
    • APIs
    • Biologics
  • Manufacturing
  • Investors
  • Media Centre
  • CSR
  • Career
    • Life At Emcure
    • Learning & Growth
    • Current Openings
  • Contact Us
  • About Us
    • Overview
    • Our Leadership
    • Milestones
    • Group Companies
      • Zuventus
      • Gennova
      • Tillomed
      • Marcan
      • Mantra
      • Emcutix
  • Science & Innovation
    • Overview
    • Formulations
    • APIs
    • Biologics
  • Manufacturing
  • Investors
  • Media Centre
  • CSR
  • Career
    • Life At Emcure
    • Learning & Growth
    • Current Openings
  • Contact Us

Outcome of Board Meeting & Financial Results Q2 FY25

administrator
admin
Date
20 June, 2025
Share:
Prev
Intimation under Regulation 30 – Incorporation of wholly-owned Subsidiary – Emcutix Biopharmaceuticals Limited 03.10.2024
Audio recording of Earnings Call – Q2 FY25
Next

Registered Office:
Plot No. P-1 & P-2, IT-BT Park,
Phase-II, M.I.D.C., Hinjawadi,
Pune - 411057, Maharashtra, India

  • corporate@emcure.com
  • 020 35040000
Facebook-f Instagram X-twitter Linkedin
Quick Links
  • Home
  • Science & Innovation
  • Formulations
  • API
  • Biologics
  • Manufacturing
  • Investors
  • Media Centre
  • CSR
  • Contact Us
Who we are
  • About Us
  • Milestones
  • Leadership
Group Companies
  • Zuventus
  • Gennova
  • Tillomed
  • Marcan
  • Mantra
  • Emcutix
Careers
  • Life at Emcure
  • Learnings & Growth
  • Current Openings

copyright © 2025, all rights reserved

  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Cookie Policy